Psychosocial supportive care for children receiving stem cell transplantation: practice patterns across centers

A C Sherman1, S Simonton, U Latif

  • 1Behavioral Medicine, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. ShermanAllenC@uams.edu

Insights

Pediatric stem cell transplant centers vary in how they address patient quality-of-life (QOL) needs. Enhancing QOL screening and using validated measures can improve supportive care for pediatric cancer survivors.

Area of Science:

  • Hematology
  • Oncology
  • Pediatric Care

Background:

  • Pediatric stem cell transplantation (SCT) carries risks for quality-of-life (QOL) deficits and late effects.
  • Current supportive care practices for addressing these needs across pediatric centers are not well understood.

Purpose of the Study:

  • To examine practice patterns in QOL screening, psychosocial support, and long-term follow-up care among pediatric SCT centers.
  • To identify variations in supportive care delivery based on center type.

Main Methods:

  • A survey was administered to 65 centers within the Pediatric Blood and Marrow Transplant Consortium (82.2% response rate).
  • Data collected included QOL screening practices, psychosocial interventions, and duration of follow-up care.

Main Results:

  • Approximately 80% of centers screened for psychological distress and pain; fewer screened for fatigue, cognitive deficits, or spiritual concerns.
  • Screening primarily used interviews, with limited use of standardized measures.
  • Community-based centers showed higher screening rates for some deficits compared to academic centers.
  • 60% offered support groups, 49.2% provided arts-in-medicine programs, and most centers offered extended follow-up (until age 21 or indefinitely).

Conclusions:

  • Pediatric SCT centers should enhance QOL screening by addressing under-scrutinized domains and incorporating validated measures.
  • The widespread provision of extended follow-up care is promising for monitoring long-term outcomes in pediatric SCT survivors.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...